Completed NA INTERVENTIONAL NCT00248352

A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease

GLUCOSE : Glucose Lowering by Usual Care Or Specialized Endocrinology Team

Sponsor: Ottawa Heart Institute Research Corporation

Conditions Coronary Disease Diabetes Mellitus, Type 2

Interventions Consultation with Endocrinologist Counseling from Diabetes Educator Counseling from Dietician

Updated 5 times since 2017 Last updated: Oct 25, 2007 Started: Feb 28, 2005 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Coronary Disease and Diabetes Mellitus, Type 2 and is currently completed. Ottawa Heart Institute Research Corporation leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ottawa Heart Institute Research Corporation
Pfizer
Sanofi

Data source: Ottawa Heart Institute Research Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottawa, Canada